Feedback / Questions
dusquetide (SGX942) - Soligenix
https://www.prnewswire.com/news-releases/fda-grants-soligenix-orphan-drug-designation-for-the-treatment-of-behcets-disease-after-reviewing-recent-phase-2-clinical-study-results-302531119.html
Aug 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next